Major medical outcomes with spinal augmentation vs conservative therapy

Brendan J. McCullough, Bryan A. Comstock, Richard (Rick) Deyo, William Kreuter, Jeffrey G. Jarvik

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

IMPORTANCE: The symptomatic benefits of spinal augmentation (vertebroplasty or kyphoplasty) for the treatment of osteoporotic vertebral compression fractures are controversial. Recent population-based studies using medical billing claims have reported significant reductions in mortality with spinal augmentation compared with conservative therapy, but in nonrandomized settings such as these, there is the potential for selection bias to influence results. OBJECTIVE: To compare major medical outcomes following treatment of osteoporotic vertebral fractures with spinal augmentation or conservative therapy. Additionally, we evaluate the role of selection bias using preprocedure outcomes and propensity score analysis. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort analysis of Medicare claims for the 2002-2006 period. We compared 30-day and 1-year outcomes in patients with newly diagnosed vertebral fractures treated with spinal augmentation (n = 10 541) or conservative therapy (control group, n = 115 851). Outcomes were compared using traditional multivariate analyses adjusted for patient demographics and comorbid conditions. We also used propensity score matching to select 9017 pairs from the initial groups to compare the same outcomes. EXPOSURES: Spinal augmentation (vertebroplasty or kyphoplasty) or conservative therapy. MAIN OUTCOMES AND MEASURES: Mortality, major complications, and health care utilization. RESULTS: Using traditional covariate adjustments, mortality was significantly lower in the augmented group than among controls (5.2%vs 6.7%at 1 year; hazard ratio, 0.83; 95%CI, 0.75-0.92). However, patients in the augmented group who had not yet undergone augmentation (preprocedure subgroup) had lower rates of medical complications 30 days post fracture than did controls (6.5%vs 9.5%; odds ratio, 0.66; 95%CI, 0.57-0.78), suggesting that the augmented group was less medically ill. After propensity score matching to better account for selection bias, 1-year mortality was not significantly different between the groups. Furthermore, 1-year major medical complications were also similar between the groups, and the augmented group had higher rates of health care utilization, including hospital and intensive care unit admissions and discharges to skilled nursing facilities. CONCLUSIONS AND RELEVANCE: After accounting for selection bias, spinal augmentation did not improve mortality or major medical outcomes and was associated with greater health care utilization than conservative therapy. Our results also highlight how analyses of claims-based data that do not adequately account for unrecognized confounding can arrive at misleading conclusions.

Original languageEnglish (US)
Pages (from-to)1514-1521
Number of pages8
JournalJAMA Internal Medicine
Volume173
Issue number16
DOIs
StatePublished - Sep 9 2013

Fingerprint

Selection Bias
Patient Acceptance of Health Care
Propensity Score
Mortality
Kyphoplasty
Vertebroplasty
Insurance Claim Review
Skilled Nursing Facilities
Compression Fractures
Control Groups
Osteoporotic Fractures
Medicare
Intensive Care Units
Cohort Studies
Multivariate Analysis
Odds Ratio
Demography
Conservative Treatment
Population
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Major medical outcomes with spinal augmentation vs conservative therapy. / McCullough, Brendan J.; Comstock, Bryan A.; Deyo, Richard (Rick); Kreuter, William; Jarvik, Jeffrey G.

In: JAMA Internal Medicine, Vol. 173, No. 16, 09.09.2013, p. 1514-1521.

Research output: Contribution to journalArticle

McCullough, Brendan J. ; Comstock, Bryan A. ; Deyo, Richard (Rick) ; Kreuter, William ; Jarvik, Jeffrey G. / Major medical outcomes with spinal augmentation vs conservative therapy. In: JAMA Internal Medicine. 2013 ; Vol. 173, No. 16. pp. 1514-1521.
@article{7d806c96e12b47c9a6d5898dd929a1e3,
title = "Major medical outcomes with spinal augmentation vs conservative therapy",
abstract = "IMPORTANCE: The symptomatic benefits of spinal augmentation (vertebroplasty or kyphoplasty) for the treatment of osteoporotic vertebral compression fractures are controversial. Recent population-based studies using medical billing claims have reported significant reductions in mortality with spinal augmentation compared with conservative therapy, but in nonrandomized settings such as these, there is the potential for selection bias to influence results. OBJECTIVE: To compare major medical outcomes following treatment of osteoporotic vertebral fractures with spinal augmentation or conservative therapy. Additionally, we evaluate the role of selection bias using preprocedure outcomes and propensity score analysis. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort analysis of Medicare claims for the 2002-2006 period. We compared 30-day and 1-year outcomes in patients with newly diagnosed vertebral fractures treated with spinal augmentation (n = 10 541) or conservative therapy (control group, n = 115 851). Outcomes were compared using traditional multivariate analyses adjusted for patient demographics and comorbid conditions. We also used propensity score matching to select 9017 pairs from the initial groups to compare the same outcomes. EXPOSURES: Spinal augmentation (vertebroplasty or kyphoplasty) or conservative therapy. MAIN OUTCOMES AND MEASURES: Mortality, major complications, and health care utilization. RESULTS: Using traditional covariate adjustments, mortality was significantly lower in the augmented group than among controls (5.2{\%}vs 6.7{\%}at 1 year; hazard ratio, 0.83; 95{\%}CI, 0.75-0.92). However, patients in the augmented group who had not yet undergone augmentation (preprocedure subgroup) had lower rates of medical complications 30 days post fracture than did controls (6.5{\%}vs 9.5{\%}; odds ratio, 0.66; 95{\%}CI, 0.57-0.78), suggesting that the augmented group was less medically ill. After propensity score matching to better account for selection bias, 1-year mortality was not significantly different between the groups. Furthermore, 1-year major medical complications were also similar between the groups, and the augmented group had higher rates of health care utilization, including hospital and intensive care unit admissions and discharges to skilled nursing facilities. CONCLUSIONS AND RELEVANCE: After accounting for selection bias, spinal augmentation did not improve mortality or major medical outcomes and was associated with greater health care utilization than conservative therapy. Our results also highlight how analyses of claims-based data that do not adequately account for unrecognized confounding can arrive at misleading conclusions.",
author = "McCullough, {Brendan J.} and Comstock, {Bryan A.} and Deyo, {Richard (Rick)} and William Kreuter and Jarvik, {Jeffrey G.}",
year = "2013",
month = "9",
day = "9",
doi = "10.1001/jamainternmed.2013.8725",
language = "English (US)",
volume = "173",
pages = "1514--1521",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "16",

}

TY - JOUR

T1 - Major medical outcomes with spinal augmentation vs conservative therapy

AU - McCullough, Brendan J.

AU - Comstock, Bryan A.

AU - Deyo, Richard (Rick)

AU - Kreuter, William

AU - Jarvik, Jeffrey G.

PY - 2013/9/9

Y1 - 2013/9/9

N2 - IMPORTANCE: The symptomatic benefits of spinal augmentation (vertebroplasty or kyphoplasty) for the treatment of osteoporotic vertebral compression fractures are controversial. Recent population-based studies using medical billing claims have reported significant reductions in mortality with spinal augmentation compared with conservative therapy, but in nonrandomized settings such as these, there is the potential for selection bias to influence results. OBJECTIVE: To compare major medical outcomes following treatment of osteoporotic vertebral fractures with spinal augmentation or conservative therapy. Additionally, we evaluate the role of selection bias using preprocedure outcomes and propensity score analysis. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort analysis of Medicare claims for the 2002-2006 period. We compared 30-day and 1-year outcomes in patients with newly diagnosed vertebral fractures treated with spinal augmentation (n = 10 541) or conservative therapy (control group, n = 115 851). Outcomes were compared using traditional multivariate analyses adjusted for patient demographics and comorbid conditions. We also used propensity score matching to select 9017 pairs from the initial groups to compare the same outcomes. EXPOSURES: Spinal augmentation (vertebroplasty or kyphoplasty) or conservative therapy. MAIN OUTCOMES AND MEASURES: Mortality, major complications, and health care utilization. RESULTS: Using traditional covariate adjustments, mortality was significantly lower in the augmented group than among controls (5.2%vs 6.7%at 1 year; hazard ratio, 0.83; 95%CI, 0.75-0.92). However, patients in the augmented group who had not yet undergone augmentation (preprocedure subgroup) had lower rates of medical complications 30 days post fracture than did controls (6.5%vs 9.5%; odds ratio, 0.66; 95%CI, 0.57-0.78), suggesting that the augmented group was less medically ill. After propensity score matching to better account for selection bias, 1-year mortality was not significantly different between the groups. Furthermore, 1-year major medical complications were also similar between the groups, and the augmented group had higher rates of health care utilization, including hospital and intensive care unit admissions and discharges to skilled nursing facilities. CONCLUSIONS AND RELEVANCE: After accounting for selection bias, spinal augmentation did not improve mortality or major medical outcomes and was associated with greater health care utilization than conservative therapy. Our results also highlight how analyses of claims-based data that do not adequately account for unrecognized confounding can arrive at misleading conclusions.

AB - IMPORTANCE: The symptomatic benefits of spinal augmentation (vertebroplasty or kyphoplasty) for the treatment of osteoporotic vertebral compression fractures are controversial. Recent population-based studies using medical billing claims have reported significant reductions in mortality with spinal augmentation compared with conservative therapy, but in nonrandomized settings such as these, there is the potential for selection bias to influence results. OBJECTIVE: To compare major medical outcomes following treatment of osteoporotic vertebral fractures with spinal augmentation or conservative therapy. Additionally, we evaluate the role of selection bias using preprocedure outcomes and propensity score analysis. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort analysis of Medicare claims for the 2002-2006 period. We compared 30-day and 1-year outcomes in patients with newly diagnosed vertebral fractures treated with spinal augmentation (n = 10 541) or conservative therapy (control group, n = 115 851). Outcomes were compared using traditional multivariate analyses adjusted for patient demographics and comorbid conditions. We also used propensity score matching to select 9017 pairs from the initial groups to compare the same outcomes. EXPOSURES: Spinal augmentation (vertebroplasty or kyphoplasty) or conservative therapy. MAIN OUTCOMES AND MEASURES: Mortality, major complications, and health care utilization. RESULTS: Using traditional covariate adjustments, mortality was significantly lower in the augmented group than among controls (5.2%vs 6.7%at 1 year; hazard ratio, 0.83; 95%CI, 0.75-0.92). However, patients in the augmented group who had not yet undergone augmentation (preprocedure subgroup) had lower rates of medical complications 30 days post fracture than did controls (6.5%vs 9.5%; odds ratio, 0.66; 95%CI, 0.57-0.78), suggesting that the augmented group was less medically ill. After propensity score matching to better account for selection bias, 1-year mortality was not significantly different between the groups. Furthermore, 1-year major medical complications were also similar between the groups, and the augmented group had higher rates of health care utilization, including hospital and intensive care unit admissions and discharges to skilled nursing facilities. CONCLUSIONS AND RELEVANCE: After accounting for selection bias, spinal augmentation did not improve mortality or major medical outcomes and was associated with greater health care utilization than conservative therapy. Our results also highlight how analyses of claims-based data that do not adequately account for unrecognized confounding can arrive at misleading conclusions.

UR - http://www.scopus.com/inward/record.url?scp=84883769814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883769814&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2013.8725

DO - 10.1001/jamainternmed.2013.8725

M3 - Article

VL - 173

SP - 1514

EP - 1521

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 16

ER -